Formaldehyde and leukemia: Epidemiology, potential mechanisms, and implications for risk assessment by Zhang, Luoping et al.
Formaldehyde and Leukemia: Epidemiology, Potential
Mechanisms and Implications for Risk Assessment
Luoping Zhang*,1, Laura E. Beane Freeman2, Jun Nakamura3, Stephen S. Hecht4, John J.
Vandenberg5, Martyn T. Smith1, and Babasaheb R. Sonawane6
1School of Public Health, University of California, Berkeley, California, USA
2Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda,
Maryland, USA
3Department of Environmental Sciences and Engineering, University of North Carolina, Chapel
Hill, North Carolina, USA
4Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA
5National Center for Environmental Assessment, Office of Research and Development, U.S.
Environmental Protection Agency, Research Triangle Park, North Carolina, USA
6National Center for Environmental Assessment, Office of Research and Development, U.S.
Environmental Protection Agency, Washington DC, USA
Abstract
Formaldehyde is widely used in the United States and other countries. Occupational and
environmental exposures to formaldehyde may be associated with an increased risk of leukemia in
exposed individuals. However, risk assessment of formaldehyde and leukemia has been
challenging due to inconsistencies in human and animal studies and the lack of a known
mechanism for leukemia induction. Here we provide a summary of the symposium at the
Environmental Mutagen Society Meeting in 2008, which focused on the epidemiology of
formaldehyde and leukemia, potential mechanisms, and implication for risk assessment, with
emphasis on future directions in multidisciplinary formaldehyde research.
Updated results of two of the three largest industrial cohort studies of formaldehyde-exposed
workers have shown positive associations with leukemia, particularly myeloid leukemia, and a
recent meta-analysis of studies to date supports this association. Recent mechanistic studies have
shown the formation of formaldehyde-induced DNA adducts and characterized the essential DNA
repair pathways that mitigate formaldehyde toxicity. The implications of the updated findings for
the design of future studies to more effectively assess the risk of leukemia arising from
formaldehyde exposure were discussed and specific recommendations were made. A
toxicogenomic approach in experimental models and human exposure studies, together with the
measurement of biomarkers of internal exposure, such as formaldehyde-DNA and protein adducts,
should prove fruitful. It was recognized that increased communication among scientists who
perform epidemiology, toxicology, biology, and risk assessment could enhance the design of
future studies, which could ultimately reduce uncertainty in the risk assessment of formaldehyde
and leukemia.
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INTRODUCTION
The International Agency for Research on Cancer (IARC) recently reclassified
formaldehyde as a human carcinogen that causes nasopharyngeal cancer [Cogliano et al.,
2005; IARC 2006] and also concluded that there is “strong but not sufficient evidence for a
causal association between leukemia and occupational exposure to formaldehyde” based on
evidence from epidemiological studies. Leukemia is a much more common tumor (incidence
rate in the general population: 12.3 per 100,000) than is nasopharyngeal cancer (0.7 per
100,000) [SEER 2006]. Therefore, determining whether there is an association between
formaldehyde exposure and leukemia is of great public health significance. However,
inconsistencies in human and animal studies have presented challenges for the evaluation of
the risk of leukemia associated with formaldehyde exposure. At the 39th Annual
Environmental Mutagen Society (EMS) Meeting in October 2008, we held a symposium at
which an up-to-date review of the epidemiological studies of formaldehyde and leukemia
and potential mechanisms were presented. We also discussed the implications for risk
assessment and how to incorporate recent findings into the design of future human exposure
and mechanistic studies. The proceedings of the symposium are reported here.
FORMALDEHYDE EXPOSURE AND LEUKEMIA
Formaldehyde exposure
Formaldehyde is an economically important chemical produced in the U.S. at a rate of over
11 billion pounds annually. It is used in the manufacture of numerous products such as
consumer appliances, porcelain-like dishware and insulation, and as a tissue preservative or
bactericide in embalming fluid and medical laboratories [Zhang et al., 2009]. In 1995, more
than 2 million workers in the US were occupationally exposed [OSHA 1995], while many
more are exposed in developing countries [Tang et al., 2009]. The current U.S. Occupational
Safety and Health Administration (OSHA) standards were established in 1992, and include a
permissible exposure limit (PEL) of 0.75 ppm (parts per million) in air as an 8-h time-
weighted average (8 h TWA) and a short-term (15 min) exposure limit (STEL) of 2 ppm
[OSHA 1992]. Despite much lower exposure limits of 0.016 ppm (8 h TWA) and 0.1 ppm
(STEL) [NIOSH 2005] recommended by the U.S. National Institute for Occupational Safety
and Health (NIOSH), the U.S. continues to retain higher occupational exposure levels
(OELs) than the current or proposed levels of many other countries or provinces including
Australia, Germany, Japan and British Columbia [CAREX-Canada 2007; JSOH 2007;
NICNAS 2006; NIOSH 2006].
Although much lower formaldehyde levels are typically encountered through environmental
than occupational exposure, a greater number of people are impacted. Outdoor environment
air concentrations in large cities sometimes exceed the NIOSH recommended exposure level
for the workplace of 0.016 ppm (=16 ppb) [NIOSH 2005] [Báez et al., 1995; Báez et al.,
2003; Chen et al., 2004; Khoder et al., 2000], and ambient levels in homes containing large
amounts of pressed wood products can exceed 0.3 ppm [USEPA 2007], much higher than
the World Health Organization’s (WHO) recommended indoor limit of 0.08 ppm [WHO-
ROE 2006], which many other countries have adopted as well [Tang et al., 2009]. Despite
this, the U.S. continues to allow the use of formaldehyde, while the Council of the European
Union has already placed formaldehyde, along with many other biocidal products, under
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strict review with the intention of eventually removing them from the European market [EU
2007].
Formaldehyde is also a naturally occurring compound that is present in human plasma at
concentrations ranging from 13 to 97 μM [Heck and Casanova 2004; Szarvas et al., 1986].
Endogenous formaldehyde and its oxidation product, formic acid, are intermediates in the
“one-carbon pool” [Neuberger 1981] used for the biosynthesis of purines, thymidine, and
some amino acids. As a naturally occurring metabolite in many living things, formaldehyde
is also found at high background levels in many types of food, such as shiitake mushrooms
and many types of seafood. There have also been instances of formaldehyde found in fruits,
vermicelli noodles, and even beer [Tang et al., 2009]. Thus formaldehyde exposure via food
consumption is also a possibility.
Formaldehyde’s pervasiveness has resulted in a number of reported health effects, including
nasopharyngeal cancer and potentially leukemia. As both the incidence and mortality rates
are higher for leukemia than for nasopharyngeal cancer, the public health implications of
leukemia are potentially more significant than that of nasopharyngeal cancer.
Epidemiology of formaldehyde and leukemia
Much of the evidence for an association between formaldehyde exposure and leukemia
comes from epidemiology studies, of which there are primarily three types: case-control
studies in the general population, proportionate mortality studies of professionals, (e.g.,
funeral industry workers and pathologists) and cohort studies of industrial workers.
Understanding exposure evaluation is important for understanding and interpreting results
from these studies. Population-based case-control studies generally rely upon job histories to
assign the probability of whether exposure occurred and may provide a category of low or
high exposure, but rarely provide an estimate of the level of exposure. Similarly, the
proportionate mortality studies conducted in professionals rely upon employment where
formaldehyde exposure likely occurred, such as in the funeral industry or among
pathologists. Cohort studies have provided the best opportunity, thus far, for evaluating
exposure-response associations.
Case control studies suggested associations between formaldehyde exposure and various
lymphohematopoietic (LHP) malignancies, but the evidence for an association with
leukemia is less certain. There are three case control studies and one nested case-control
study [Blair et al., 2001; Linos et al., 1990; Partanen et al., 1993; Ott et al., 1989] that have
specifically examined associations with leukemia. Although they all provide some evidence
of an association with formaldehyde exposure and leukemia, these studies have a small
number of exposed cases, ranging from 1 to 61 exposed, making confidence intervals wide
and exposure-response analyses difficult or impossible.
Early epidemiological studies of formaldehyde exposure in industrial manufacturing
environments did not show an association between formaldehyde and leukemia [Zhang et
al., 2009]. However, studies of professionals exposed to formaldehyde, such as embalmers,
mortuary workers, medical examiners, pathologists, and anatomists, showed excesses of
leukemia [Hall et al., 1991; Hayes et al., 1990; Levine et al., 1984; Matanoski 1991; Milham
Jr 1983; Walrath and Fraumeni 1983; Walrath and Fraumeni 1984]. Recently, three of the
largest cohorts in industrial settings have been updated, and two of the three did find an
association between formaldehyde exposure and leukemia. The first included 14,014
workers in British chemical factories where formaldehyde was used or produced. Exposure
was assessed by creating a job exposure matrix and assigning each job to one of five
categories of exposure. Leukemia rates were compared to a local group, and no association
was observed between either employment in the factories (Standardized Mortality Ratio,
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SMR=0.91; 95% CI: 0.62–1.29) or work in a high exposure group (SMR=0.71; 95% CI:
0.31–1.39) [Coggon et al., 2003]. Myeloid leukemia was not examined specifically.
The second industrial cohort was conducted by NIOSH and included 11,039 workers from
the garment industry, where fabrics are treated with formaldehyde resins [Pinkerton et al.,
2004]. In an exposure assessment based on 594 randomly selected employees the mean
exposure levels were 0.09–0.20 ppm and were relatively constant with no peaks or
intermittent exposures. For leukemia, the highest SMR occurred with those who had been
employed in the garment factory ten or more years (SMR=1.53) and more than twenty years
since the first exposure (SMR=1.31). Results were stronger for myeloid leukemia, with the
SMR=2.19 for employment of ten or more years and SMR=1.91 for those who had first
been exposed more than twenty years ago.
The third study, conducted by the U.S. National Cancer Institute (NCI), included 25,619
participants [Hauptmann et al., 2003]. Exposure assessment included a number of time-
dependent exposure metrics, duration, cumulative exposure, average 8-hour time-weighted
average intensity and highest peak category of exposure. The exposure assessment ended in
1980, when only 11% of the workers were still employed in formaldehyde-exposed jobs.
The study demonstrated associations with formaldehyde exposure and leukemia overall, but
the stronger associations were seen for myeloid leukemia. For the highest level of average
intensity of exposure, the relative risk (RR) for myeloid leukemia was 2.49 (95% confidence
interval, CI: 1.03–6.03), and 3.46 (95% CI: 1.27–9.43) for the highest category of peak
exposure compared to workers with lower exposures.
Since the EMS symposium in October 2008, a more recent update of the NCI cohort has
been published [Beane Freeman et al., 2009], which includes ten years of additional follow-
up from the previous publication. The study found that the overall risk of myeloid leukemia
had decreased since the last publication, but still remained somewhat elevated (RR=1.61;
95% CI: 0.76–3.39, Ptrend=0.4 for average intensity exposure; RR=1.78; 95% CI: 0.87–3.64,
Ptrend=0.07 for peak exposure). Although the risks have diminished since the previous report
from the cohort, the pattern of larger risks occurring closer in time to relevant exposure and
diminishing as time progresses is not inconsistent with a causal association. Conversely,
they may also indicate that the previous stronger association was due to chance.
The epidemiological literature on formaldehyde and leukemia is extensive. Many, but not all
of the studies have suggested associations. Since these studies took place in varied settings
with different co-exposures, it is unlikely that uncontrolled confounders explain these
results. More studies are needed to explore potential mechanisms and to establish if there is
heterogeneity in association between the leukemia subtypes.
New meta-analysis of formaldehyde and leukemia
Zhang et al. recently performed a meta-analysis of epidemiological studies based on the
hypothesis that high formaldehyde exposure can induce leukemia, particularly myeloid type
[Zhang et al., 2009]. Unlike past analyses, this new meta-analysis’ novel approach focused
on both industrial and professional subjects with the highest exposure and selected RR
estimates for myeloid leukemia (the primary type of leukemia associated with
formaldehyde) whenever possible, to prevent dilution of RR estimates toward the null that
occur when examining ever vs. never exposure. The results (Table I) showed a strong
association between formaldehyde and leukemia, and suggested that formaldehyde exposure
can increase risk of leukemia by 54% (RR=1.54; 95% CI: 1.18–2.00), particularly myeloid
leukemia (RR=1.90; 95% CI: 1.31–2.76). Compared to the largest national cohort discussed
in the previous section, risk estimates of the peak exposures are very similar for all types of
blood cancers, all types of leukemia, and myeloid leukemia [Beane Freeman et al., 2009].
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Table I summarizes and compares the 4 past and present meta-analyses. For all types of
blood cancers and all professions, Zhang 2009 and Collins 2004 found similar positive risk
estimates [Collins and Lineker 2004;Zhang et al., 2009], while Bosetti 2008 found a
significant increase in RR only in professional workers but not industrial workers [Bosetti et
al., 2008]. The risk estimates for all leukemias are positive for professional workers, and
across the 3 older meta-analyses, risk estimates for industrial workers are inconclusive.
Discrepancies found between these meta-analyses are a result of study and exposure group
selection, and inclusion and exclusion criteria, which have all been discussed at length in the
recent Zhang 2009 meta-analysis. And although past meta-analyses also included similar
studies and data, this meta-analysis serves as an example of how a focused hypothesis, strict
selection criteria, and meticulous review of all existing studies can strengthen the assessment
of leukemia risks from formaldehyde exposures.
BIOLOGICAL PLAUSIBILITY AND POTENTIAL MECHANISMS
As discussed above, numerous epidemiological studies and a recent meta-analysis support
the association of formaldehyde exposure with leukemia. However, due to its reactive
nature, it has been considered unlikely that inhaled formaldehyde could damage stem cells
in the bone marrow directly and cause leukemia similar to classical leukemogens. It has
been previously suggested that formaldehyde could potentially reach bone marrow directly
in its hydrate methanediol form. Two alternative mechanisms have been proposed, by which
formaldehyde could cause leukemia through damage to hematopoietic stem/progenitor cells
circulating in the peripheral blood and through damage to the primitive pluripotent stem
cells present within the nasal turbinates and/or olfactory mucosa [Zhang et al., 2009]. In the
latter two models, damaged stem/progenitor cells would then travel to the bone marrow and
become initiated leukemic stem cells, potentially developing into leukemia following a
protracted latency. Given the likely dynamics of stem cell turnover between the nasal/oral
passages, blood and bone marrow [Barnett et al., 1999; Bryder et al., 2006; Murrell et al.,
2005], sufficient stem cells could be targeted through these two alternative models to induce
leukemia, under conditions of chronic high formaldehyde exposure (such as occupational
exposure).
The “insufficient evidence” for an association with formaldehyde and leukemia concluded
by IARC was based on the inability of the Working Group to identify a mechanism for
leukemia induction [IARC 2006]. Most leukemogens exert their effects on stem or
progenitor cells in the bone marrow, causing hematotoxicity and/or genotoxicity. The
published data on formaldehyde hematotoxicity are limited and inconsistent [Kuo et al.,
1997; Madison et al., 1991; Vargova et al., 1993; Ye et al., 2005] and future studies are
needed to clarify the hematotoxic effects of formaldehyde in exposed people.
Although endogenous formaldehyde is usually rapidly metabolized by reduction, oxidation,
and reduced glutathione (GSH)–dependent pathways, excess levels such as those
encountered occupationally and/or environmentally, could saturate metabolic capacity and
lead to genotoxicity in DNA and chromosomes.
Formaldehyde-induced DNA and chromosome damage
Formaldehyde is genotoxic, inducing both DNA damage expressed as DNA adducts [Wang
et al., 2007] and DNA–protein crosslinks (DPCs) and chromosome changes, expressed as
chromosomal aberrations (CA), sister chromatid exchanges (SCEs), and micronuclei (MN).
These alterations have been demonstrated by a large number of studies in vitro, in exposed
animals, and to varying degrees in the circulating lymphocytes of exposed people [ATSDR
1999; IARC 2006; Iarmarcovai et al., 2007; Orsiere et al., 2006; Wang et al., 2007; Ye et al.,
2005; Yu et al., 2005]. As discussed previously, more molecular epidemiological studies
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examining the genotoxic effects of formaldehyde are needed [Zhang et al., 2009]. For
example, the only human studies performed to date showing elevated DPCs in the peripheral
mononuclear cells of formaldehyde-exposed workers [Shaham et al., 2003; Shaham et al.,
1996], need to be replicated due to the excessively high levels of DPCs reported in the
controls.
Studies showing increased CA in humans have a number of methodological weaknesses,
including poor exposure assessment, non-current measurement of exposure and outcome,
small sample size, etc, necessitating replication of the findings in better-designed studies
[Bauchinger and Schmid 1985; Chebotarev et al., 1986; He et al., 1998; Kitaeva et al., 1996;
Lazutka et al., 1999; Vozenilkova et al., 1991]. Despite these limitations, many studies
report positive results indicating that formaldehyde is able to cause a range of genotoxic
effects in the DNA and chromosomes of lymphocytes, and possibly other bone marrow-
derived cells. Recent studies have investigated the potential mechanisms underlying DNA
damage [Wang et al., 2007] and the DNA repair pathways [Ridpath et al., 2007] induced by
formaldehyde.
The FANC-BRCA pathway and DNA damage response
DPCs appear to be critical DNA lesions for formaldehyde-induced carcinogenesis. DPC
level has been used as a biomarker of formaldehyde exposure in mammalian cells [Casanova
et al., 1994; Casanova et al., 1991], and has also been correlated with formaldehyde-induced
carcinogenesis in animals [Hubal et al., 1997; IRIS 1998]. However, little is known about
which DNA damage response pathways are essential for cells to counteract damage from
formaldehyde exposure. Yamazoe et al. investigated the DNA damage response to
formaldehyde using a reverse genetic approach in the chicken DT40 cell model system
[Yamazoe et al., 2004] by first assessing targeted mutations in various DNA repair or cell
cycle checkpoint response pathway genes. As measured by the survival of DT40-derived
mutants, results revealed a requirement for the homologous recombination (HR) pathway,
but not the non-homologous end joining (NHEJ pathway), in processing DNA damage
induced by formaldehyde, strongly suggesting that the HR pathway is involved in repair of
DPCs. DT40 mutants deficient in REV1, REV3, and RAD18 but not genes involved in
translesion synthesis, showed hypersensitivity to formaldehyde, in agreement with the
findings from an earlier study of DNA-DNA intercrosslinking agents, including cisplatin
and mitomycin C [Nojima et al., 2005]. In contrast, the ATM pathway showed no major
contribution in the DNA damage response to formaldehyde-induced DNA damage.
Fanconi anemia, an inherited disorder associated with progressive bone marrow failure and
predisposition to malignant leukemia and solid tumors, is characterized by sensitivity to
DNA interstrand crosslinking agents and an associated increase in chromosomal breakage
[Kennedy and D’Andrea 2005]. Given this sensitivity, the role of genes in the FANC
(Fanconi anemia complementation group) pathway in the response to formaldehyde-induced
DNA damage was investigated by the Nakamura laboratory [Ridpath et al., 2007]. FANC
proteins are closely related to the breast/ovarian cancer susceptibility gene products BRCA1
and BRCA2, and to their partner proteins, and the FANC pathway is also called the “FANC-
BRCA pathway” [D’Andrea and Grompe 2003] or “FANC-BRCA network” [Venkitaraman
2004]. FANCD1 (BRCA2)–deficient and FANCD2-deficient chicken DT40 cells were most
hypersensitive to formaldehyde at concentrations irrelevant to human exposure.
Furthermore, the same study showed that human RKO cells deficient in FANCC and
FANCG were also hypersensitive to plasma levels of formaldehyde at concentrations 20
μmol/L or higher (FANCC) or 38 μmol/L or higher (FANCG) [Ridpath et al., 2007]. In
addition, FANCD2-deficient DT40 cells, the most sensitive cell line to formaldehyde, were
hypersensitive to acetaldehyde, but not to acrolein, crotonaldehyde, glyoxal, and
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methylglyoxal. These results indicate that the FANC-BRCA pathway is essential to
counteract DPCs caused by formaldehyde and other aliphatic monoaldehydes.
Figure 1, adapted from data by Jacquemont and Taniguchi, summarizes all of the genes
known to be involved in the resistance to DPC induced by formaldehyde [Jacquemont and
Taniguchi 2007]. Eight FANC proteins (FANC-A, -B, -C, -E, -F, -G, -L and -M), a
FANCM-interacting protein called FAAP24, and an unidentified factor (FAAP100) form a
nuclear complex (the FANC core complex) with E3 ubiquitin ligase activity. FANCL, the
catalytic subunit of the Fanconi anemia core complex, directly interacts with the E2
ubiquitin conjugating enzyme UBE2T. In response to DNA damage (e.g., DPC) caused by
formaldehyde, the FANCD2 protein is monoubiquitylated targeting it into nuclear foci
where it co-localizes with BRCA1, FANCD1/BRCA2, FANCN/PALB2, RAD51, FANCJ/
BRIP1 and other proteins. Many of these factors appear to be required for cellular resistance
to formaldehyde. Reduced activity in one or more of these genes involved in the DNA
damage response could render an individual hyper-susceptible to DPC induced by
formaldehyde [Jacquemont and Taniguchi 2007].
It is hypothesized that the induction of DPCs by endogenous formaldehyde plays a critical
role in the initiation of progressive bone marrow failure or predisposition to malignant
tumors in Fanconi anemia patients. Exposure to exogenous sources of formaldehyde could
push susceptible individuals into a dangerous zone in which genotoxic levels of DPC are
induced. One of the big limitations to this hypothesis is the uncertainty over whether
exogenous formaldehyde can reach the bone marrow. A mouse model, such as a FANC
deficient mouse could be a useful tool to better understand whether formaldehyde causes
bone morrow toxicity by inhalation. Such a model would also allow us to investigate the
potential role of endogenous formaldehyde on the etiology of acute myeloid leukemia in
Fanconi anemia patients.
Detection of formaldehyde-DNA adducts
DNA adducts are critical in the process of carcinogenesis because, if unrepaired, they lead to
mutations in important growth control genes, ultimately resulting in genomic instability and
cancer. While several formaldehyde DNA adducts have been identified in vitro, notably the
dAdo cross-link, di-N6-deoxyadenosylmethane (dAdo-CH2-dAdo), and its precursor, N6-
hydroxymethyl-dAdo (N6-HOCH2-dAdo) [Cheng et al., 2003], they had not been previously
analyzed in laboratory animals exposed to formaldehyde or its precursors. The Hecht
laboratory developed a highly sensitive, accurate, and precise liquid chromatography–
electrospray ionization–tandem mass spectrometry–selected reaction monitoring (LC-ESI-
MS/MS-SRM) method to quantify these adducts [Wang et al., 2007]. They applied the
method to analyze hepatic and pulmonary DNA from rats treated with the strongly
carcinogenic nitrosamines N-nitrosodimethylamine (NDMA) and 4-(methylnitrosamino)-1-
(3-pyridyl)-1-butanone (NNK), which release formaldehyde upon cytochrome P450
catalyzed metabolic activation [Hecht 1998; Preussmann and Stewart 1984]. Results such as
those shown in Figure 2 clearly demonstrated the dose-dependent presence of N6-HOCH2-
dAdo in all DNA samples, along with well-established nitrosamine-DNA adducts such as 7-
methylguanine and O6-methylguanine [Wang et al., 2007]. The cross-link adduct dAdo-
CH2-dAdo was observed in hepatic DNA of NNK-treated rats, with lower amounts in
pulmonary DNA, and in hepatic DNA of NDMA-treated rats. Levels of these adducts were
generally lower than those of DNA adducts formed by the classical diazohydroxide pathway
of nitrosamine metabolism. This was the first demonstration of formaldehyde-DNA adducts
in tissues of laboratory animals. The biological significance of these adducts requires further
investigation.
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The Hecht laboratory is presently analyzing N6-HOMe-dAdo in human leukocyte DNA.
Once standardized, this assay should be useful in directly assessing DNA damage as
formaldehyde-DNA adducts in humans, and could be applied in molecular epidemiology
studies of formaldehyde and cancer.
IMPLICATIONS FOR THE HEALTH RISK EVALUATION OF FORMALDEHYDE
The U.S. EPA is evaluating potential human health risks from environmental exposures to
formaldehyde as part of the Integrated Risk Information System (IRIS) [IRIS 1998]. Both
cancer and non-cancer outcomes are being evaluated and the resulting assessment will
provide qualitative (hazard identification) and, if possible, quantitative (dose-response)
evaluations. The IRIS toxicological review may then be coupled with estimates of human
exposures to formaldehyde to estimate potential risks to exposed populations, thereby
supporting informed decision making under statutes such as the Clean Air Act, as amended
in 1990 [USEPA 1990]. Importantly, the qualitative and quantitative assessment of
formaldehyde includes characterization of the nature and strength of the evidence as well as
characterization of uncertainty in interpreting and using available data. The case of
formaldehyde-induced LHP malignancies presents challenges in these areas resulting in
uncertainties in the risk evaluation.
Uncertainties in hazard identification arise from interpretation and extrapolation of data
from both experimental animal and human epidemiological studies. Data from in vivo and in
vitro laboratory studies are evaluated in terms of study protocol, limitations of study design,
selection of endpoints of toxicity and their relevance to humans and coherence across levels
of biological organization. Epidemiological studies may present uncertainties in exposure
estimation, appropriate dosimetrics, misclassification of disease, confounding exposures,
unidentified risk factors and use of an appropriate referent population. Evidence related to
mode of action, such as induction of formaldehyde-induced DNA adducts and chromosome
damage, and the FANC-BRCA pathway, may help to support evaluation of the biological
plausibility of the epidemiological findings. The EPA’s 2005 Cancer Guidelines [USEPA
2005a] and Supplemental Guidance [USEPA 2005b] to protect children recommend the use
of human data, where adequate and appropriate, for quantitative risk assessment. Recent
developments, not only in hazard identification, but also mode and mechanism of action of
formaldehyde on hematopoietic and immune cells provide an increasingly informed basis on
which to evaluate the utility of human studies for human health risk assessment of
formaldehyde exposure.
FUTURE DIRECTIONS
The updated findings discussed here suggest that future studies are warranted to more
effectively assess the risk of leukemia arising from formaldehyde exposure. It was
recognized that increased communication among risk assessment scientists, epidemiologists,
toxicologists, and biologists would enhance the design of such studies, and reduce some of
the uncertainty associated with risk assessment. Accordingly, the following specific
recommendations have been made.
Several approaches were suggested to address gaps in knowledge regarding the association
between formaldehyde and leukemia. Although leukemia arises from damaged blood stem
cells, little is known about the sensitivity of blood stem cells to formaldehyde and whether
formaldehyde produces mutations related to leukemia in these cells. As discussed above,
some studies report that formaldehyde produces chromosome damage in circulating blood
cells of exposed humans, but it is not known if it also does so in blood progenitor/stem cells
or how consistent its effects are. Studies of CD34+ cells exposed to formaldehyde in culture
were suggested to address these issues.
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Molecular epidemiology/biomarker studies of occupationally exposed populations should be
designed to determine whether formaldehyde causes hematotoxicity, as this has not been
definitively shown. A biomarker discovery approach should be applied in these studies using
toxicogenomic, proteomic, and metabolomic tools. Leukemia-specific markers, such as
chromosome translocations, should be examined in peripheral blood leukocytes and
progenitor cells. Together, the study of leukemia-specific chromosome damage in cultured
CD34+ cells and of hematoxicity in human populations will strengthen the biological
plausibility and help to elucidate a mode of action.
Members of the audience proposed that further studies in transgenic mice with DNA repair
deficiencies are one possible future research direction. The determination of whether
adducts are formed in the bone marrow of mice treated with formaldehyde-generating
chemicals and whether the FANC-BRCA pathway is involved in the response to such
damage in the bone marrow could help to determine if exogenous formaldehyde reaches the
bone marrow. The potential application of the Pig-A mutation assay and/or a knockout
mouse model to clarify the mechanisms of formaldehyde-induced leukemogenesis was also
proposed. These various research approaches will provide lines of evidence that can be used
to ascertain causality.
Finally, it was recognized that because few tools are available to measure formaldehyde
exposure internally, chemical-specific methodologies to specifically detect adducts of
formaldehyde to DNA and proteins in blood, bone marrow and other target tissues are
urgently needed. The recently developed assay for the formaldehyde-DNA adduct N6-
HOMe-dAdo in leukocytes is one example. The ability to accurately measure formaldehyde
exposure would address one of the key aspects of causality judgment in risk assessment, that
of biologic gradient or exposure-response relationship. According to this relationship,
increasing effects associated with greater exposure strongly suggest cause and effect.
Swenberg and colleagues recently demonstrated that formaldehyde can cross-link GSH with
DNA by forming S-[1-(N2-deoxyguanosinyl)methyl]glutathione in the test tube, and
proposed utilizing this adduct as a biomarker of formaldehyde exposure and toxicity [Lu et
al., 2009]. Further, the authors proposed that this adduct, coupled with isotope-labeled
formaldehyde, could differentiate between endogenous and exogenous origin of
formaldehyde-derived adducts. In conclusion, much of the uncertainty in the risk assessment
of formaldehyde and leukemia could be limited through a concerted effort among all
associated disciplines in the design of future studies. Risk assessment does not weigh one
type of evidence against another, but rather weighs all of the evidence taken together.
Research that strengthens the consistency, strength, specificity, exposure-response
relationship, or biological plausibility of an observed association, or that provides
experimental evidence in human populations, will aid in making supportable causality
judgments.
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Proposed model of DNA damage response pathways for DNA damage caused by
formaldehyde (FA). Adapted with modifications from [Jacquemont and Taniguchi 2007]. In
response to DNA damage (e.g., DPC) caused by formaldehyde, the FANCD2 protein is
monoubiquitylated on lysine 561 (K561) in a Fanconi anemia core complex- and UBE2T-
dependent manner that also requires ATR and RPA. Monoubiquitylation of FANCD2 is
thought to target the protein into nuclear foci where it co-localizes with BRCA1, FANCD1/
BRCA2, FANCN/PALB2, RAD51, FANCJ/BRIP1 and other proteins. Many of these
factors appear to be required for cellular resistance to formaldehyde. Monoubiquitylation of
PCNA on lysine 164 (K164) may require RAD6 as an E2 and RAD18 as an E3. In turn,
modification of PCNA may cause recruitment of translesion synthesis (TLS) DNA
polymerases at the site of stalled replication forks.
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Liquid Chromatography-electrospray ionization-tandem mass spectrometry-selected ion
monitoring (LC-ESI-MS-SIM) analysis of an enzymatic hydrolysate of hepatic DNA from a
rat treated with NDMA [Wang et al., 2007]. Peaks corresponding to the retention times of
standard 7-Me-dGuo, N6-HOCH2-dAdo and O6-Me-dGuo were observed. (A) The peak
eluting at 47.0 min had a base peak at m/z 282 [M + H]+, similar to standard N6-HOCH2-
dAdo. (B) LC-ESI-MS-SIM analysis (m/z 515) showed a peak at 85.8 min, corresponding to
the retention time of dAdo-CH2-dAdo.
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